Eucrates Biomedical Acquisition Corp.
Financials · Blank Checks · D8 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$698,578 | −$743,071 | −$151,051 |
| Net income | $2.4M | $3.8M | −$4.9M |
| Total assets | $12.5M | $105.1M | $105.8M |
| Total liabilities | $3.9M | $5.8M | $10.3M |
| Equity | −$3.7M | −$5.5M | −$9.3M |
| EPS (diluted) | — | — | — |
| Shares out. | 13.5M | 13.5M | 3.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −65.1%
- Return on assets
- 19.4%
- Return on capital (ROCE)
- −5.6%
- Liabilities / assets
- 31.6%
- Debt / equity
- —
- Book value / share
- $-0.28
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- −36.7%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -2.30distress
- Accruals / assets
- 24.4%high accruals
- Piotroski F-Score
- 3/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 2 warning● 1 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 29, 2023
- NT 10-Qmissed a reporting deadline ↗May 16, 2022
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2022
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2021
- NT 10-Qmissed a reporting deadline ↗May 17, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Saxena ParagOfficer — Chief Executive Officer | Nov 24, 2020 | J | 255,094 | — |
| Papadopoulos SteliosDirector | Nov 24, 2020 | J | 255,094 | — |
| Eucrates Llc10% owner | Nov 24, 2020 | J | 255,094 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Other material eventApr 11, 2023
- New financial obligationApr 3, 2023
- Entered a material agreement · New financial obligation · Unregistered equity saleFeb 16, 2023
- New financial obligationNov 8, 2022
- Amended charter or bylawsOct 31, 2022
- Shareholder vote · Regulation FD disclosureOct 24, 2022
- Entered a material agreement · New financial obligation · Unregistered equity saleJan 26, 2022
- Prior financials not reliable (restatement)Nov 19, 2021
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GMay 8, 2023
- 25-NSEApr 26, 2023
- 10-KApr 13, 2023
- 8-KFORM 8-KApr 11, 2023
- 8-KFORM 8-KApr 3, 2023
- NT 10-KMar 29, 2023
- 8-KFORM 8-KFeb 16, 2023
- SC 13G/AFeb 10, 2023
- 10-QNov 14, 2022
- SC 13GNov 9, 2022
- 8-KFORM 8-KNov 8, 2022
- 8-KFORM 8-KOct 31, 2022
- 8-KFORM 8-KOct 24, 2022
- DEF 14AOct 12, 2022
- UPLOADOct 12, 2022
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.